Exosens Announces a 23.2% Revenue Growth in the First Nine Months of 2025
Exosens, a specialist in detection and imaging technologies, achieved a revenue of 327.8 million euros in the first nine months of 2025, marking an increase from the previous year, according to the company's press release.
Exosens' revenue reached 327.8 million euros in the first nine months of 2025, up by 23.2% compared to the same period in 2024, as per the company's statement. The Amplification segment saw a significant rise of 20.6%, reaching 231.8 million euros, driven by increased demand for image intensifier tubes in the Defense sector. The Detection & Imaging segment also showed growth, with revenues of 97.0 million euros, an increase of 26.2%. The adjusted gross margin for this period stood at 168.0 million euros, up by 28.7%.
Strategic Acquisitions and Divestitures
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
Almost there! Check your inbox.
A confirmation email has been sent. Click the link to confirm your subscription.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
In 2025, Exosens completed several strategic acquisitions, including those of Noxant and NVLS, aimed at strengthening their technology portfolio and expanding their potential market in Defense. The company also acquired Phasics, a leader in wavefront analysis technology. Concurrently, Exosens divested its Microwave Amplification business to focus on higher growth segments. An investment plan of 37 million euros was announced to increase production capacity by 40% by 2027.
Market Demand and Future Outlook
Amid high demand for Defense technologies, Exosens has experienced increasing demand for its night vision systems and detectors, supported by geopolitical tensions and budget increases in the Defense sector. The company expects to maintain its growth with an anticipated revenue increase in the upper range of 15-20% for the year 2025, and an adjusted EBITDA growth in the lower range of 20-25%, thanks to its strategy of internal and external growth.
Nous sommes fiers de présenter notre performance sur les neuf premiers mois de l’année 2025, qui témoignent d'une croissance soutenue du chiffre d'affaires et de la marge brute ajustée, portée par la forte dynamique du secteur de la Défense.
Marché de la Défense très dynamique, forte demande pour la vision nocturne et les systèmes pour drones/anti-drones, croissance soutenue en Europe avec contribution des États-Unis et de l’Asie-Pacifique. Lancement commercial réussi des tubes 5G (plus de 5 000 commandes avant lancement).
Risks mentioned
Cession de l’activité Amplification par Micro-ondes entraînant une perte comptable sans impact de trésorerie en 2025
Dépendance aux budgets de Défense et aux évolutions géopolitiques
Risque d'intégration des acquisitions récentes
Incertitudes de la demande dans les Sciences de la Vie (marché américain)
Opportunities identified
Croissance adressable liée à la vision nocturne et aux applications drones/anti-drones
Commercialisation des tubes 5G avec commandes significatives (>5 000 tubes)
Expansion des capacités de production (+40% d’ici 2027) soutenant le développement commercial
Effets de croissance externe (Noxant, NVLS, Phasics) élargissant le marché adressable
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
